Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
View all » 
Recent Releases
May 3, 2012
Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
View all »Events
May 15, 2012 at 2:00 PM PT
JMP Securities 11th Annual Research Conference
May 8, 2012 at 4:50 PM ET
Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
| Stock Quote |
|---|
| CADX - (NASDAQ)
$2.90 + 0.09 May 16, 2012 4:00 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.